Brucella: Animal to Human Transmission

Brucellosis is often called an invisible threat because it silently spreads from animals to humans, causing a debilitating illness that can persist for months. This bacterial infection, caused by various species of Brucella, represents one of the most widespread zoonotic diseases transmitted by animals. Understanding how this pathogen jumps from livestock to people is essential for anyone working with animals or consuming animal products.

What is Brucella? 🔗

Brucella species are Gram-negative coccobacilli bacteria that primarily infect domestic animals but can cause serious disease in humans. The three main species affecting humans are B. melitensis (from goats and sheep), B. abortus (from cattle), and B. suis (from pigs). Among these, B. melitensis is the most prevalent species causing human brucellosis worldwide, particularly in regions where immunizing free-ranging goats and sheep proves challenging.

These bacteria are facultative intracellular parasites, meaning they can survive and multiply inside human cells, specifically within monocyte-macrophage cells. This characteristic makes the infection particularly difficult to treat and contributes to the chronic nature of the disease.

How does transmission occur from animals to humans? 🔗

The journey of Brucella from animals to humans follows several distinct pathways, each presenting unique risks.

Consumption of contaminated animal products 🔗

The most common route of infection is through eating or drinking unpasteurized dairy products, including raw milk, fresh cheese, butter, and ice cream from infected animals. In infected ruminants, enormous numbers of bacteria are shed through milk, making dairy products a significant vehicle for transmission. Additionally, consuming undercooked meat from infected cattle, sheep, goats, pigs, or game animals like bison, elk, and wild hogs can introduce the bacteria into the human body.

Direct contact with infected animals 🔗

People can contract brucellosis through direct handling of infected animals, particularly during birthing processes. Workers who come into contact with blood, placenta, fetuses, and uterine secretions face increased risk of infection. The bacteria can enter through small cuts or abrasions on the skin, or through mucous membranes in the eyes, nose, or mouth.

Inhalation of contaminated aerosols 🔗

Brucella bacteria spread easily through the air in dust particles or aerosols. Breathing in bacteria-laden air represents a significant risk, especially in enclosed spaces like slaughterhouses, meat-processing facilities, and laboratories. This route of transmission is particularly concerning for laboratory workers, as brucellosis remains the most commonly reported laboratory-associated bacterial infection.

Who is at highest risk? 🔗

Certain occupations and activities significantly increase exposure to Brucella bacteria. Veterinarians and veterinary staff face dual risks from both examining infected animals and potential accidental self-injection when administering vaccines. Slaughterhouse workers and butchers encounter infected tissues and body fluids regularly during their work.

Farmers and animal breeders, particularly those working with cattle, sheep, goats, and pigs, experience frequent contact with potentially infected animals. Hunters who field-dress game animals or handle infected carcasses can contract the infection through skin contact or inhalation. Laboratory personnel working with Brucella specimens require strict safety protocols to prevent infection.

In the general population, most cases result from consuming raw milk or its derivatives, particularly fresh cheeses from sheep and goat products. Travelers to regions where brucellosis is endemic, including Latin America, the Mediterranean area, Central Asia, and countries around the Arabian Gulf, face increased risk when consuming local unpasteurized dairy products.

Recognizing the symptoms of brucellosis 🔗

The clinical presentation of brucellosis varies considerably, making diagnosis challenging. The incubation period typically ranges from one to four weeks after exposure, though it can extend up to several months. Initial symptoms often mimic influenza, creating diagnostic uncertainty.

Common early symptoms include fever reaching 38 to 40°C, severe limb and back pain, profuse sweating, and marked fatigue. Many patients experience malaise, headache, loss of appetite, and muscle aches. The disease may present as an undulant fever, where symptoms intensify and recede in cycles lasting about 10 days.

Without proper treatment, some patients develop complications affecting various organ systems. These can include arthritis (particularly affecting the spine and large joints), endocarditis (heart valve infection), neurological involvement with meningitis, and reproductive system complications. Unlike in animals, abortion is not a typical feature of brucellosis in pregnant women.

Diagnosing Brucella infection 🔗

Accurate diagnosis of brucellosis requires laboratory confirmation because clinical symptoms alone are nonspecific and variable. The diagnostic approach combines culture methods and serological testing.

Blood culture methods 🔗

Blood culture remains the gold standard for diagnosis, particularly in early disease stages. Modern automated blood culture systems can detect acute cases within the routine five to seven-day incubation period, though prolonged incubation and blind subcultures may be necessary for chronic cases. Culture specimens should be obtained early in the disease course for optimal results.

However, blood cultures have limitations. Isolation rates typically range from 20-50% even in experienced laboratories, with particularly low success rates for B. abortus infections. Bone marrow cultures and specimens from focal infection sites may prove more successful when blood cultures fail.

Serological testing 🔗

Serological tests detect antibodies against Brucella bacteria and remain the diagnostic mainstay, especially in resource-limited settings. The standard tube agglutination test measures antibodies against smooth lipopolysaccharide. Some serology tests require two serum samples: the first collected within seven days of symptom onset, and the second two to four weeks later to compare antibody levels.

Modern enzyme immunoassays differentiate between specific IgM and IgG antibodies, providing better interpretation of the clinical situation. IgM antibodies typically appear during the first week after infection, followed by IgG antibodies in the second week. Both antibody types peak around the fourth week of infection.

Interpretation of serological results requires caution. Persistent antibody levels may indicate remaining infection foci, while rising titers suggest active disease or relapse. Single high titers can be difficult to interpret due to subclinical infections and variable individual responses. Additionally, infections with B. canis and Brucella RB51 cannot be detected through standard serological testing and require culture confirmation.

Prevention strategies 🔗

Preventing brucellosis requires a multi-faceted approach targeting both animal populations and human behavior. At the population level, the most effective prevention strategy is eliminating infection in animals through vaccination of cattle, goats, and sheep in high-prevalence areas, combined with serological testing and culling programs.

For individuals, avoiding consumption of unpasteurized dairy products represents the single most important preventive measure. Pasteurization effectively destroys Brucella bacteria in milk and milk products. When traveling to endemic regions, consuming only pasteurized dairy products significantly reduces infection risk.

Occupational protection requires proper personal protective equipment for those working with animals or animal products. This includes wearing impermeable clothing, rubber boots and gloves, face masks or respirators, and goggles when handling animal tissues, body fluids, or potentially contaminated materials. Good personal hygiene practices, including thorough handwashing, further reduce transmission risk.

What do you think? How can healthcare workers better identify brucellosis in patients who may not report animal exposure? What additional measures could reduce transmission risk in communities where raw dairy consumption is traditional?

References

1. https://www.who.int/news-room/fact-sheets/detail/brucellosis
2. https://www.ncbi.nlm.nih.gov/books/NBK8572/
3. https://www.cdc.gov/brucellosis/about/index.html
4. https://www.cdc.gov/brucellosis/hcp/clinical-overview/index.html